Contact dermatitis. II. Clinical aspects and diagnosis

European Journal of Dermatology

Volumn 9, Issue 2, 1999, Pages 144-159

  Krasteva, Maya ^a   Kehren, Jeanne ^a   Sayag, Michèle ^b   Ducluzeau, Marie Thérèse ^a   Dupuis, Monique ^c   Kanitakis, Jean ^c   Nicolas, Jean François ^d  

^a INSERM   (France)

^b Laboratoire Bioderma   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d NONE

Author keywords

Contact dermatitis; Contact sensitivity; Haptens

Indexed keywords

AGENTS ACTING ON THE EYE; ALLERGEN; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID; COSMETIC; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETRETIN; IRRITANT AGENT; METAL; STEROID;

ANAMNESIS; ANGIOSPERM; CLINICAL FEATURE; CLOTHING; DRUG ERUPTION; EXPOSURE; HAND ECZEMA; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; ORAL DRUG ADMINISTRATION; PATCH TEST; PHYSICAL EXAMINATION; PLANT DERMATITIS; PUVA; REVIEW; SKIN ALLERGY; SKIN INFLAMMATION; SKIN MANIFESTATION; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET RADIATION;

EID: 0032899911     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Krasteva M, Kehren J, Ducluzeau MT, Sayag M, Cacciapuoti M, Akiba H, Descotes J, Nicolas JF. Pathophysiology of contact sensitivity (CME series). Eur J Dermatol 1999; 1: 65-77.
2. Veien KN. Systemically induced eczema in adults. Acta Derm Venereol 1989; 147 (suppl.): 1-48.
3. Klaschka F, Ring J. Systemically induced (hematogenous) contact eczema. Semin Dermatol 1990; 9: 210-5.
4. Gawkrodger DJ, McVittie E, Carr M, Ross JA. Phenotypic characterisation of the early cellular responses in allergic and irritant contact dermatitis. Clin Exp Immunol 1986; 66: 590-8.
5. Silvennoinen-Kassinen S, Ikäheimo I, Karvonen J, Kauppinen M, Kallioinen M. Mononuclear cell subsets in the nickel-allergic reaction in vitro and in vivo. J Allergy Clin Immunol 1992; 89: 794-800.
6. Markey AC, Allen MH, Pitzalis C, Mac Donald DM. T cell inducer populations in cutaneous inflammation: a predominance of T helper-inducer lymphocytes (TH1) in the infiltrate of inflammatory dermatoses. Br J Dermatol 1990; 122: 325-32.
7. Wilkinson SM, Andrew SM, Maseruka H, Beck MH. Immunohistochemical appearance of corticosteroid contact hypersensitivity reactions. Contact Dermatitis 1994; 31: 304-7.
8. Möller H, Larsson A, Bjorkner B, Bruze M. The histological and immunohistochemical pattern of positive patch test reactions to gold sodium thiosulfate. Acta Derm Venereol 1994; 74: 417-23.
9. Kalish RS. Recent developments in the pathogenesis of allergic contact dermatitis. Arch Dermatol 1991; 127: 1558-63.
10. +T-lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 1992; 98: 59-63.
11. Brasch J, Burgard J, Sterry W. Common pathogenetic pathways in allergic and irritant contact dermatitis. J Invest Dermatol 1992; 98: 166-70.
12. Friedmann PS, Strickland I, Memon AA, Johnson PM. Early time course of recruitment and immune surveillance in human skin after chemical provocation. Clin Exp Immunol 1993; 91: 351-6.
13. Gueniche A, Viac J, Lizard G, Charveron M, Schmitt D. Effect of different sensitizing haptens on intercellular adhesion molecule-1 expression and cytokine production by normal human keratinocytes. Eur J Dermatol 1995; 5: 320-5.
14. Wilkinson JD, Rycroft RJG. Contact dermatitis. In: A. Rook, D.S. Wilkinson, F.J.G. Ebling, eds. Textbook in Dermatology. IV, Oxford, Blackwell Scientific Publications, 1986: 435-68.
15. Fisher T, Maibach HI. Finn chamber patch test technique. Semin Dermatol 1984; 11: 137-40.
16. Drake LA, Dorner W, Goltz RW, Graham GF, Lewis CW, Pariser DM, Solasche SJ, Skouge JW, Turner MLC, Lowery BJ. Guidelines of care for contact dermatitis. J Am Acad Dermatol 1995; 32: 109-13.
17. Manuskiatti W, Maibach HI. 1- versus 2- and 3-day diagnostic patch testing. Contact Dermatitis 1996; 35: 197-200.
18. Johansen JD, Menné T. The fragrance mix and its constituents: a 14-year material. Contact Dermatitis 1995; 32: 18-23.
19. Bashir S, Maibach HI. Compound allergy. An overview. Contact Dermatitis 1997; 36: 179-83.
20. Bruynzeel DP, Andersen KE, Camarasa JG, Lachapelle JM, Menné T, White I. The European standard series. Contact Dermatitis 1995; 33: 145-8.
21. Lachapelle JM, Ale SI, Freeman S, Frosch PJ, Goh CL, Hannuksela M, Hayakawa R, Maibach HI, Wahlberg JE. Proposal for a revised international series of patch tests. Contact Dermatitis 1997; 36: 121-3.
22. Menné T, Dooms-Goossens A, Wahlberg JE, White I, Shaw S. How large a proportion or contact sensitivities are diagnosed with the European contact dermatitis series. Contact Dermatitis 1992; 26: 201-2.
23. Marks JG, Belsito DV, DeLeo VA, Fowler JF, Fransway AF, Maibach HI, Mathias CGT, Nethercott JR, Rietschel RL, Sherertz EF, Storrs FJ, Taylor JS. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol 1998; 38: 911-8.
24. Dooms-Goossens A. Testing without a kit. In: J.D. Guin, ed. A handbook for the practitioner. New York: McGraw-Hill Inc., 1995: 63-74.
25. Rietschel RL, Adams RM, Maibach HI. The case of patch test reading beyond day 2. J Am Acad Dermatol 1988; 18: 42-5.
26. Shehade SS, Beck MH, Hillier VF. Epidemiological survey of standard series patch test results and observations on day 2 and day 4 readings. Contact Dermatitis 1991; 24: 119-22.
27. Vigan M, Girardin P, Adessi B, Laurent R. Late reading of patch tests. Eur J Dermatol 1997; 7: 574-6.
28. Adams RM, Fisher T. Diagnostic patch testing. In: R.M. Adams, eds. Occupational skin disease. 2nd edition. Philadelphia: W.B. Saunders, 1990: 223-53.
29. Fisher T, Maibach HI. Diagnostic patch testing. Contact Dermatitis 1984; 11: 137-40.
30. Berardesca E, Maibach HI. Bioengineering and the patch test. Contact Dermatitis 1988; 18: 3-9.
31. Van der Steen PH, Hopple R. Topical immunotherapy of alopecia areata. Dermatol Clin 1993; 11: 619-22.
32. Fisher T, Maibach HI. Patch testing in allergic contact dermatitis. An update. Semin Dermatol 1986; 5: 214-24.
33. Fisher T, Rystedt I. False positive, follicular and irritant patch test reactions to metal salts. Contact Dermatitis 1985; 13: 93-8.
34. Lachapelle JM. A proposed relevance scoring system for positive allergic patch test reactions: practical implications and limitations. Contact Dermatitis 1997; 36: 39-43.
35. De Groot AC. Test concentrations and vehicles for 3700 chemicals. In: eds. Patch testing. Amsterdam: Elsevier, 1994: 324.
36. Larsson-Stymne B, Widstöm L. Ear piercing, a cause of contact dermatitis in school girls. Contact Dermatitis 1985; 13: 289-93.
37. Menné T. Prevention of nickel allergy by regulation of specific exposures. Ann Clin Lab Sci 1996; 26: 133-8.
38. Delescluse J, Dinet Y. Nickel allergy in Europe: The new European legislation. Dermatology 1994; 189 (suppl. 2): 56-7.
39. Dooms-Goossens A, Kerre S, Drieghe J, Bossuyt L, Degreef H. Cosmetic products and their allergens. Eur J Dermatol 1992; 2: 465-8.
40. De Groot A. Contact allergy to cosmetics: causative ingredients. Contact Dermatitis 1987; 17: 26-34.
41. De Groot AC, Frosch PJ. Adverse reactions to fragrances. A clinical review. Contact Dermatitis 1997; 36: 57-86.
42. Johansen JD, Rastogi SC, Andersen KE, Menné T. Content and reactivity to product perfumes in fragrance mix positive and negative eczema patients. A study of perfumes used in toiletries and skin-care products. Contact Dermatitis 1997; 36: 291-6.
43. Marks JG. Cosmetics. In: R.M. Adams, ed. Occupational skin disease. 2nd edition. Philadelphia: W.B. Saunders, 1990: 223-53.
44. De Groot AC, de Cock PA, Coenraads PJ, van Ginkel CJ, Jagtman BA, van Joost T, Joost van der Kley AM, Meinardi MM, Smeenk G, van der Valk PG, van der Walle HB, Weyland JW. Methyldibromoglutaronitrile is an important contact allergen in The Netherlands. Contact Dermatitis 1996; 34: 118-20.
45. Van Ginkel CJW, Rundervoort GJ. Increasing incidence of contact allergy to the new preservative 1,2-dibromo-2,4-dicyanobutane (methyldibromoglutaronitrile). Br J Dermatol 1995; 132: 918-20.
46. De Groot AC, van der Walle HB, Weyland JW. Contact allergy to cocamidopropyl betaine. Contact Dermatitis 1995; 33: 419-22.
47. Liden C, Berg M, Färm G, Wrangsjö K. Nail varnish allergy with far reaching consequences. Br J Dermatol 1993; 128: 57-62.
48. Hatch KL, Maibach H. Textile dye dermatitis. J Am Acad Dermatol 1995; 32: 631-9.
49. Dooms-Goossens A, Andersen KE, Brandao FM, Bruynzeel D, Burrows D, Camarasa J, Ducombs G, Frosch P, Hannuksela M, Lachapelle JM, Lahti A, Menné T, Wahlberg JE, Wilkinson JD. Corticosteroid contact allergy: an EECDRG multicentre study. Contact Dermatitis 1996; 35: 40-4.
50. Whitmore SE. Delayed systemic allergic reaction to corticosteroids. Contact Dermatitis 1995; 32: 193-8.
51. Zenarola P, Gimma A, Lomuto M. Systemic contact dermatitis from thiomersal. Contact Dermatitis 1995; 32: 107-8.
52. Schmidt RJ, Hausen BM, Adams RM, Epstein WL, Mitchell JC. Plants, woods, poison ivy and poison oak, and frullania. In: R.M. Adams, ed. Occupational skin disease. 2nd edition. Philadelphia: W.B. Saunders, 1990: 503-45.
53. Fregert S. Manual of contact dermatitis. 2nd edition. Copenhagen: Munksgaard, 1981.
54. Griffiths WAD. Industrial dermatitis - A national problem. In: W.A.D. Griffiths, D.S. Wilkinson, eds. Essentials of industrial dermatology. Oxford: Blackwell, 1984: 1-34.
55. Berardinelli SP. Prevention of occupational skin disease through use of protective gloves. Dermatol Clin 1988; 6: 115-9.
56. Adams RM. Job descriptions with their irritants and allergens. In: R.M. Adams, eds. Occupational skin disease. 2nd edition. Philadelphia: W.B. Saunders, 1990: 578-691.
57. Maibach HI. Occupational and industrial dermatology. Chicago: Yearbook Medical Publishers, 1987.
58. Hogan OJ, Dannaker CJ, Maibach HI. Contact dermatitis: prognosis, risk factors and rehabilitation. Semin Dermatol 1990; 9: 233-46.
59. Mathias CG. Contact dermatitis and workers' compensation: criteria for establishing occupational causation and aggravation. J Am Acad Dermatol 1989; 20: 842-48.
60. Taylor JS. Occupational dermatoses. In: M.H. Alderman, M.J. Hanley, eds. Clinical medicine for the occupational physician. New York: Dekker, 1982: 299-312.
61. Dannaker CJ, White IR, Rycroft RJG. Long-term prognosis in occupational chromate allergy: an attempted 18 year follow-up study. Contact Dermatitis 1989; 21: 59-63.
62. Weltfriend S, Bason M, Lammintausta K, Maibach H. Irritant contact dermatitis (irritation). In: F.N. Marzulli, H.I. Maibach, eds. Dermatotoxicology. Washington: Taylor & Francis, 1996: 87-118.
63. Judge MR, Griffiths HA, Basketter DA, White IR, Rycrott RJG, McFadden JP. Variation in response of human skin to irritant challenge. Contact Dermatitis 1996; 34: 115-17.
64. Veien NK, Hattel T, Laurberg G. Low nickel diet: an open, prospective trial. J Am Acad Dermatol 1993; 29: 1002-7.
65. Granlund H, Erkko P, Reitamo S. Comparison of cyclosporin and topical betamethasone- 17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol1996; 76: 371-6.
66. Orfanos CE, Ehlert R, Gollnick H. The retinoids. A review of their clinical pharmacology and therapeutic use. Drugs 1987; 34: 459-503.
67. Kligman AM. Cashew nut shell oil for hyposenitization against rhus dermatitis. Arch Dermatol 1958; 78: 359-63.
68. Bagot M, Charue D, Flechet ML, Terki N, Toma A, Revuz J. Oral desensitization in nickel allergy induces a decrease in nickel-specific T cells. European J Dermatology 1995; 5: 614-8.
69. Panzani RC, Schiavino D, Nucera E, Pellegrino S, Fais G, Schinco G, Patriarca G. Oral hyposensitization to nickel allergy: preliminary clinical results. Int Arch Allergy Immunol 1995; 107:251-4.
70. Troost RJJ, Kozel MMA, van Helden-Meeuwsen CG, van Joost T, Mulder PGH, Benner R, Prens E. Hyposensitization in nickel allergic contact dermatitis: clinical and immunologic monitoring. J Am Acad Dermatol 1995; 32: 576-83.
71. Dolhain R, Elferink BG, Leow A, Witvliet MD, Claas FHJ, Struyk L, Vermeer BJ, Breedveld FC, Devries RRP. T cell vaccination in patients with nickel allergic contact dermatitis. J Invest Dermatol 1995; 105: 143-4.
72. Funk JO, Maibach HI. Horizons in pharmacologic intervention in allergic contact dermatitis. J Am Acad Dermotol 1994; 31: 999-1014.
73. Krasteva M, Nicolas JF. Eczéma de contact. Perspectives thérapeutiques. Objectif Peau 1996; 4: 442-4.
74. Enk AH. Allergic contact dermatitis: understanding the immune response and potential for targeted therapy using cytokines. Mol Med Today 1997; 3: 423-8.